河南金丹乳酸科技股份有限公司 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2023-001 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|---------------------------------------|------------------------------------------------------| | 投资者关系活动 | □特定对象调研 □ | 分析师会议 | | 类别 | □ 媒体采访 √ | 业绩说明会 | | | □ 新闻发布会 □ | 路演活动 | | | □ 现场参观 | | | | √ 其他：河南辖区上市公司 | 2023 年投资者网上集体接待日活动 | | 参与单位名称及 | | | | | 全体投资者 | | | 人员姓名 | | | | 时间 | 2023 年 5 月 18 | 日（星期四）下午 14:30~17:30 | | 地点 | 全景网"投资者关系互动平台"（ | https://ir.p5w.net） | | 上市公司接待人 | 1、董事长张鹏 ...

证券代码：300829 证券简称：金丹科技 公告编号：2023-033 河南金丹乳酸科技股份有限公司 关于参加河南辖区上市公司 2023 年投资者网上集体接待日 活动暨召开 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司（以下简称"公司"）于 2023 年 4 月 21 日 发布了公司《2022 年年度报告》，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，进一步加强与投资者的互动交流，公司定于 2023 年 5 月 18 日（星期四）16:00-17:20 在全景网参加"真诚沟通 传递价值"河南辖 区上市公司 2023 年投资者网上集体接待日活动暨举办 2022 年度业绩说明会，就 投资者关心的问题进行交流。本次活动将采用网络远程的方式举行，投资者可登 录"全景·路演天下"(http:/rs.p5w.net)参与本次互动交流。 出席本次活动的人员有：公司董事长张鹏先生、董事会秘书崔耀军先生、财 务总监陈飞先生、保荐代表人解明先生、独立董事张复生先生（如有特殊情况， 参会人员 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥324,258,192.62, a decrease of 14.12% compared to ¥377,584,484.39 in the same period last year[4] - Net profit attributable to shareholders decreased by 64.01% to ¥15,543,631.08 from ¥43,185,548.57 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 66.20% to ¥13,583,173.25 compared to ¥40,191,601.14 in the previous year[4] - The net profit for the first quarter of 2023 is CNY 13,000,277.81, a decrease of 69.5% compared to CNY 42,585,093.25 in the same period last year[18] - The total revenue from operating activities decreased to CNY 324,555,049.55, down 6.4% from CNY 348,317,821.29 in the previous year[20] - The company reported a total comprehensive income of CNY 12,994,664.40, down 69.6% from CNY 42,782,635.56 in the previous year[18] - The company's operating profit for the first quarter is CNY 14,877,662.83, a decrease of 68.3% from CNY 46,911,171.33 in the same period last year[18] Cash Flow and Assets - The net cash flow from operating activities was negative at -¥24,689,688.78, a decline of 219.11% from ¥20,727,718.72 in the same period last year[4] - The net cash flow from operating activities is negative at CNY -24,689,688.78, compared to a positive CNY 20,727,718.72 in the same period last year[21] - Cash and cash equivalents at the end of the period increased to CNY 413,968,610.61, compared to CNY 248,188,732.85 at the end of the same period last year[21] - The company's cash and cash equivalents reached 417,765,443.11 yuan, significantly up from 262,311,763.07 yuan, marking a growth of 59.4%[14] - The company's total assets increased to 2,844,969,736.54 yuan, up from 2,506,336,264.56 yuan at the beginning of the year, representing a growth of 13.5%[15] - Current assets rose to 882,937,445.82 yuan, an increase of 30% from 679,880,037.39 yuan at the start of the year[14] - The total liabilities of the company were reported at 1,289,756,535.43 yuan, compared to 964,117,727.84 yuan previously, reflecting a 33.8% increase[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,064[9] - The equity attributable to shareholders increased by 1.02% to ¥1,541,931,717.94 from ¥1,526,392,016.25 at the end of the previous year[4] - The equity attributable to shareholders of the parent company was 1,541,931,717.94 yuan, up from 1,526,392,016.25 yuan, showing a slight increase of 1%[15] Operational Challenges - The decline in net profit was primarily due to decreased sales and prices of lactic acid products and increased prices of key raw materials like corn and coal[8] - The total operating costs amounted to 312,580,589.55 yuan, down 6.3% from 333,632,362.38 yuan year-on-year[16] - The net profit margin for the period was impacted by increased research and development expenses, which totaled 9,980,229.02 yuan, compared to 13,279,160.25 yuan in the previous period, reflecting a decrease of 24.3%[16] Strategic Initiatives - The company has received government subsidies amounting to ¥2,861,681.54 during the reporting period[5] - The company plans to issue convertible bonds to unspecified investors, which has been approved by the Shenzhen Stock Exchange[11] - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[16]

Financial Performance - The company's operating revenue for 2022 was ¥1,534,615,763.09, representing a 6.41% increase compared to ¥1,438,361,302.74 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥132,230,306.43, a 2.36% increase from ¥132,711,426.20 in 2021[21]. - The net profit after deducting non-recurring gains and losses was ¥128,909,384.66, showing a significant increase of 21.00% from ¥110,063,045.66 in 2021[21]. - The net cash flow from operating activities reached ¥161,589,312.52, a remarkable increase of 209.94% compared to ¥48,729,701.04 in 2021[21]. - The total assets at the end of 2022 amounted to ¥2,506,336,264.56, reflecting a 14.95% increase from ¥2,185,402,728.73 at the end of 2021[21]. - The net assets attributable to shareholders increased by 8.45% to ¥1,526,392,016.25 at the end of 2022, up from ¥1,411,047,163.27 in 2021[21]. - The basic earnings per share for 2022 was ¥0.73, a slight increase of 1.39% from ¥0.72 in 2021[21]. - The company reported a total of ¥3,320,921.77 in non-recurring gains for 2022, down from ¥22,648,380.54 in 2021[27]. - The company’s lactic acid product revenue was CNY 861.89 million, accounting for 56.16% of total revenue, with a slight increase of 0.32%[76]. - The revenue from lactic acid salts surged by 25.68% to CNY 297.51 million, representing 19.39% of total revenue[76]. - Domestic sales contributed CNY 1,014.17 million, which is 66.09% of total revenue, with a growth of 4.36%[76]. - International sales increased by 10.65% to CNY 520.44 million, making up 33.91% of total revenue[76]. Dividend Distribution - The company plans to distribute a cash dividend of 1.1 RMB per 10 shares to all shareholders, based on a total of 180,654,547 shares[3]. - The cash dividend distribution accounted for 100% of the total profit distribution amount, reflecting the company's commitment to shareholder returns[180]. - The company distributed a cash dividend of RMB 0.75 per 10 shares, totaling RMB 13,549,091.03 (including tax) for the year 2021[178]. Corporate Governance - The company has established a comprehensive internal control system to ensure effective execution of its operational strategies and risk management[183]. - The company has maintained a governance structure that supports effective decision-making and operational transparency[182]. - The company has a structured remuneration decision-making process that requires approval from the board of directors and the supervisory board, followed by shareholder meeting approval[161]. - The company has appointed independent directors with extensive academic and professional backgrounds, enhancing governance and oversight[160]. - The company has established a management system for hedging activities to improve operational compliance and risk oversight[111]. - The company has established a comprehensive risk management framework to monitor and mitigate potential risks identified during the reporting period[173]. Research and Development - The company is focusing on expanding its biodegradable materials research and development initiatives[150]. - The company has invested in R&D for new products and technologies in collaboration with universities to enhance its product offerings[136]. - The company’s R&D expenses increased by 11.53% to 58,531,399.45 CNY in 2022[84]. - The number of R&D personnel increased by 3.49% to 178, while the proportion of R&D personnel in the total workforce decreased slightly to 13.54%[89]. - The company is in the pilot stage of several key technology projects, including the development of high-efficiency lactic acid production methods and biodegradable materials[90]. Market Expansion and Strategy - The company plans to continue expanding its market presence and investing in new technologies to enhance production efficiency and product offerings[30]. - The company is actively pursuing market expansion and capacity enhancement through project adjustments and new product developments[121]. - The company is committed to maintaining its competitive edge by optimizing production processes and developing new products to mitigate price competition risks[136]. - The company is focused on building a biodegradable circular industry chain from lactic acid to polylactic acid to enhance product value and promote transformation and upgrading[138]. Environmental Compliance - The company strictly adhered to environmental protection laws and regulations during its operations, including the Environmental Protection Law and the Water Pollution Prevention Law[199]. - The total wastewater discharge was 186.57 tons per year, with no exceedances reported[199]. - The company maintained a CODcr discharge of 136.288 tons per year, complying with the 100 mg/L standard[199]. - The company reported a total nitrogen discharge of 90.69 tons per year, adhering to the 45 mg/L standard[200]. - The company’s sulfur dioxide emissions were recorded at 19.44 tons per year, within the permissible limits[200]. Investment and Financial Management - The company has made substantial investments in the development of new technologies and products, particularly in biodegradable materials[103]. - The company has established a procurement control system that includes supplier evaluation and contract management, ensuring that procurement meets production needs and is conducted efficiently[190]. - The investment management system requires feasibility reports for projects, with investment decisions approved by the general manager or board based on the investment amount, ensuring strict control over investment scale and risk[192]. - The company has implemented a comprehensive budget management system to clarify responsibilities and enforce budget constraints across all departments[187]. Shareholder Engagement - The company has conducted annual and temporary shareholder meetings with participation rates of 59.27% and 52.99%, respectively, indicating strong shareholder engagement[147]. - The company has maintained a stable shareholding structure with no significant changes in shareholdings among key executives[149]. - The company’s board members have extensive experience in the industry, with backgrounds in various managerial roles[151][152].

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2020-004 | --- | --- | --- | |----------------|------------------------|--------------------------| | | √ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ 其他 | | | | 太平洋证券：柳强 | | | | 东北证券：王栋，陈俊杰 | | | | 国君资管：蒋文超 | | | 参与单位名称及 | 鹏华基金：马猛 | | | 人员姓名 | 嘉实基金：陈景诚 | | | | 银华基金：侯杰瀚 | | | | 东方基金：刘腾尧 | | | 时间 | 2020 年 6 月 3 | 日上午 9:40-10:50 | | 地点 | 腾讯会议（电话调研） | | 河南金丹乳酸科技股份有限公司 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | - ...

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2020-005 河南金丹乳酸科技股份有限公司 | --- | --- | --- | |-------------------------|--------------------------|------------------------------------| | | √ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ 其他 | | | | 西南证券：杨林，薛聪 | | | | 西部证券：杨晖 | | | 参与单位名称及 人员姓名 | 广发证券：吴鑫然 | | | | 嘉实基金：王子建，陈景诚 | | | | 敦和资产：梁作强 | | | 时间 | 2020 年 6 月 8 | 日下午 17:00-18:20 | | 地点 | 公司五楼会议室 | | | 上市公司接待人 | 金丹科技营销总监申介健； | | | 员姓名 | 证券事务代表刘彦宏； ...

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2020-003 河南金丹乳酸科技股份有限公司 | --- | --- | --- | |----------------|--------------------------|--------------------------| | | √ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ 其他 | | | 参与单位名称及 | 国盛证券：孙琦祥，罗雅婷 | | | 人员姓名 | 太平洋证券：柳强 | | | | 东北证券：王栋 | | | | 中信证券：黄庭耀 | | | | 东方证券：倪吉 | | | | 中庚基金：刘晟 | | | | 博时基金：陈铖 | | | | 中欧基金：王习 | | | | 财通基金：唐家伟 | | 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | --- | |----------------|----- ...

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2021-001 河南金丹乳酸科技股份有限公司 | --- | --- | --- | |-----------------------|----------------------------------------------------------------------|----------------------------------------------------------| | 投资者关系活动 \n类别 | □ 特定对象调研 \n□ 媒体采访 \n□ 新闻发布会 \n□ 现场参观 \n□ 其他 | □ 分析师会议 \n 业绩说明会 \n 路演活动 | | 参与单位名称及 | 参与公司 2020 | 年度网上业绩说明会的投资者 | | 人员姓名 | | | | | 2021 年 5 月 6 日下午 | 15:00-17:00 | | 时间 | | | | 地点 | 全景网"投资者关系互动平台"（ | http://ir.p5w.net ） | | | 金丹科技董事长： ...

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2022-001 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|-------------------------------------------------------------------|----------------------------------------------------------| | | | | | | □ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 √ | 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 参与公司 2021 | 年度网上业绩说明会的投资者 | | 时间 | 2022 年 4 月 29 日 ( | 周五 ) 下午 15:00~17:00 | | 地点 | 公司通过全景网 " 络远程的方式召开 ...

Financial Performance - The company's revenue for Q3 2022 was CNY 352,074,729.54, a decrease of 0.83% compared to the same period last year, while year-to-date revenue increased by 14.34% to CNY 1,158,796,302.22[3] - Net profit attributable to shareholders for Q3 2022 was CNY 19,796,634.13, down 51.49% year-on-year, and year-to-date net profit decreased by 2.88% to CNY 107,937,987.15[3] - The company reported a decrease of 45.33% in net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022[7] - The company's net profit for the period was impacted by an investment loss of CNY 6,642,296.10, contrasting with a profit of CNY 3,056,718.15 in the previous period[17] - The net profit for the third quarter of 2022 was CNY 102,975,003.80, a decrease of 6.3% compared to CNY 109,524,642.51 in the same period last year[18] - Operating profit for the third quarter was CNY 113,710,627.23, down from CNY 118,613,886.99, reflecting a decline of 4.8%[18] - The company reported a total comprehensive income of CNY 103,879,879.60 for the quarter, slightly down from CNY 109,132,207.85 in the same quarter last year[18] - Basic and diluted earnings per share were both CNY 0.60, down from CNY 0.62 in the previous year[18] Cash Flow and Liquidity - The net cash flow from operating activities increased by 410.65% year-to-date, amounting to CNY 173,660,037.07, primarily due to a 14.34% increase in revenue and significant tax refunds from the government[7] - The net cash flow from operating activities was CNY 173,660,037.07, significantly higher than CNY 34,007,899.75 in the previous year, marking an increase of 411.5%[19] - Cash and cash equivalents increased to CNY 292,835,228.66 from CNY 215,336,744.31, marking a rise of approximately 36%[15] - Cash and cash equivalents at the end of the period reached CNY 292,835,228.66, compared to CNY 115,034,303.67 at the end of the previous year, indicating a substantial increase[20] - The cash flow from investing activities showed a net outflow of CNY 268,426,860.17, compared to a net outflow of CNY 158,323,983.26 in the same period last year[19] - The cash flow from financing activities generated a net inflow of CNY 171,744,010.44, an increase from CNY 101,688,735.23 in the previous year[20] Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 2,393,629,244.77, reflecting a 9.78% increase from the end of the previous year[3] - As of September 30, 2022, the company's total assets amounted to CNY 2,393,629,244.77, an increase from CNY 2,180,361,543.12 at the beginning of the year, reflecting a growth of approximately 9.8%[15] - The company's total liabilities as of September 30, 2022, were CNY 871,836,088.56, compared to CNY 748,399,175.50 at the start of the year, representing an increase of about 16.5%[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,236, with the largest shareholder holding 32.69% of the shares[9] Government Support - Government subsidies recognized during the reporting period amounted to CNY 4,255,697.22, contributing positively to the financial results[4] Costs and Expenses - The company experienced increased raw material costs, including coal and liquid alkali, contributing to the decline in profit margins[7] - The total operating costs for the period were CNY 1,037,715,886.88, compared to CNY 909,318,418.56 in the previous period, which is an increase of around 14.1%[17] - The company reported a significant increase in research and development expenses, which rose to CNY 44,045,458.25 from CNY 37,217,938.51, representing an increase of approximately 18.5%[17] Future Plans - The company plans to issue convertible bonds to raise up to CNY 700 million to invest in a new biodegradable material project with an annual production capacity of 75,000 tons[11] Return on Equity - The weighted average return on equity for the year-to-date was 7.37%, a decrease of 0.84% compared to the previous year[3] Inventory and Retained Earnings - The company's inventory decreased to CNY 211,872,645.84 from CNY 245,538,183.20, reflecting a decline of about 13.7%[15] - The company's retained earnings grew to CNY 648,244,623.32 from CNY 553,855,727.19, reflecting an increase of approximately 17%[17] Borrowings - The company's short-term borrowings increased to CNY 376,601,202.91 from CNY 295,876,808.30, indicating a rise of about 27.3%[16]